Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 3/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 1.00 |
| ▸ | CA2 | P00918 | 5/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | CA4 | P22748 | 2/20 | 0.56 |
| ▸ | CA6 | P23280 | 2/20 | 0.56 |
| ▸ | CA7 | P43166 | 2/20 | 0.56 |
| ▸ | NT5E | P21589 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL418399 | 1.00 | CA5A (1.00) | CA5ACA5BCA2TSHRCA1 | |
| Sulfuric Acid SCHEMBL3699224 | 1.00 | CA5A (1.00) | CA5ACA5BCA2TSHRCA1 | |
| Sulfuric Acid SCHEMBL8532128 | 1.00 | CA5A (1.00) | CA5ACA5BCA2TSHRCA1 | |
| Sulfuric Acid SCHEMBL113 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL2555505 | 1.00 | CA5A (1.00) | CA5ACA5BCA2TSHRCA1 | |
| Sulfuric Acid SCHEMBL110268 | 1.00 | CA5A (1.00) | CA5ACA5BCA2TSHRCA1 | |
| Sulfuric Acid SCHEMBL434526 | 1.00 | CA5A (1.00) | CA5ACA5BCA2TSHRCA1 | |
| Sulfuric Acid SCHEMBL23440695 | 0.93 | CA5A (0.86) | CA5ACA5BCA2TSHRCA1 | |
| Sulfuric Acid SCHEMBL21813307 | 0.93 | CA5A (0.86) | CA5ACA5BCA2TSHRCA1 | |
| Sulfuric Acid SCHEMBL22639007 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 532 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3624807-B1 | USE OF OLIGOSACCHARIDE COMPOUNDS FOR TREATING WOUNDS OF ARTERIOPATHIC DIABETIC PATIENTS | URGO RECH INNOVATION ET DEVELOPPEMENT (FR) | 2021-07-07 | — | — | EP | claimed |
| EP-3386490-B1 | FILM INCLUDING A POLYSULFATED OLIGOSACCHARIDE AND A POLYCATION AND METHOD FOR MANUFACTURING SAME | URGO RECH INNOVATION ET DEVELOPPEMENT (FR) | 2021-04-14 | — | — | EP | claimed |
| EP-3624807-A1 | USE OF OLIGOSACCHARIDE COMPOUNDS FOR TREATING WOUNDS OF ARTERIOPATHIC DIABETIC PATIENTS | Urgo Recherche Innovation et Développement (FR) | 2020-03-25 | — | — | EP | claimed |
| WO-2018210969-A1 | USE OF OLIGOSACCHARIDE COMPOUNDS FOR TREATING WOUNDS OF ARTERIOPATHIC DIABETIC PATIENTS | URGO RECHERCHE INNOVATION ET DEVELOPPEMENT (FR) | 2018-11-22 | — | — | WO | claimed |
| EP-3386490-A1 | FILM INCLUDING A POLYSULFATED OLIGOSACCHARIDE AND A POLYCATION AND METHOD FOR MANUFACTURING SAME | Urgo Recherche Innovation et Développement (FR) | 2018-10-17 | — | — | EP | claimed |
| EP-3377072-A1 | USE OF OLIGOSACCHARIDE COMPOUNDS FOR ACTIVATING ANGIOGENESIS | Urgo Recherche Innovation et Développement (FR) | 2018-09-26 | — | — | EP | claimed |
| WO-2017098118-A1 | FILM INCLUDING A POLYSULFATED OLIGOSACCHARIDE AND A POLYCATION AND METHOD FOR MANUFACTURING SAME | URGO RECHERCHE INNOVATION ET DEVELOPPEMENT (FR) | 2017-06-15 | — | — | WO | claimed |
| CN-104507506-B | Control the dressing of release bioactive agent | 优格医疗用品公司 | 2016-09-07 | — | — | CN | claimed |
| EP-2645932-B1 | BLOOD COLLECTION DEVICES CONTAINING BLOOD STABILIZATION AGENT | BECTON DICKINSON CO (US) | 2016-03-02 | — | — | EP | claimed |
| CN-104507506-A | Dressing having the controlled release of active agents | URGO LAB | 2015-04-08 | — | — | CN | claimed |
| WO-2014020031-A1 | COMPOSITION COMPRISING A SUCROSE OCTASULPHATE AND A SPECIFIC EMOLLIENT | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2014-02-06 | — | — | WO | claimed |
| WO-2013160065-A1 | FORMULATION CONTAINING CAPRYLIC ACID ETHANOLAMIDE AND/OR CAPROIC ACID ETHANOLAMIDE IN COMBINATION WITH AN ALUMINUM SALT | EVONIK INDUSTRIES AG (DE) | 2013-10-31 | — | — | WO | claimed |
| EP-1221937-B1 | HYBRID MATRICES AND HYBRID MATRIX MIXTURES | TRANSKARYOTIC THERAPIES INC (US) | 2004-12-15 | — | — | EP | claimed |
| EP-1383512-B1 | USE OF SUCRALFATE FOR THE TREATMENT OF CERVICAL EROSION | FARMIGEA SPA (IT) | 2004-09-08 | — | — | EP | claimed |
| EP-0469010-B1 | COSMETIC COMPOSITION | BM RES AS (DK) | 1996-02-28 | — | — | EP | claimed |
| EP-0394333-B1 | USES OF SULPHATED SUGARS | BUKH MEDITEC (DK) | 1995-03-15 | — | — | EP | claimed |
| WO-1994028020-A1 | A METHOD FOR THE PREPARATION OF INTERFERONS | BUKH MEDITEC A/S (DK) | 1994-12-08 | — | — | WO | claimed |
| WO-1994000476-A1 | USE OF WATER-SOLUBLE SUCROSES FOR THE TREATMENT AND/OR PREVENTION OF LESION OR INFLAMMATION IN THE DIGESTIVE TRACT | BUKH MEDITEC A/S (DK) | 1994-01-06 | — | — | WO | claimed |
| EP-0302155-B1 | Preparation of a new diosmine derivate | ESPANOLA PROD QUIMICOS (ES) | 1993-10-27 | — | — | EP | claimed |
| EP-0302155-A1 | Preparation of a new diosmine derivate | FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (ES) | 1989-02-08 | — | — | EP | claimed |